Clinical trial

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

NCT02408432

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-01-11

PhasePHASE1

Study timeline

Study start (actual)2016-01-11Date precision: day

Registry last updated2022-05-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiomyopathyunresolved

Heart Failureunresolved

Interventions

Laboratory Biomarker AnalysisOTHER

Standard of CareOTHER

Mesenchymal Stem Cell TransplantationDRUG

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02408432 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.